KeyBanc Lifts Solventum to Overweight, Cites Post-Spin Momentum and M&A
KeyBanc upgraded Solventum (NYSE:SOLV) from Sector Weight to Overweight and set a $97.00 price target, pointing to the company's strong start since separating from 3M, recent acquisition activity and a valuation below peers. The firm highlighted a path to meeting or exceeding a 4-5% organic growth target ahead of its 2028 timeline and noted a chang…